{
    "Trade/Device Name(s)": [
        "Xpert Carba-R",
        "Xpert Carba-R Assay"
    ],
    "Submitter Information": "Cepheid",
    "510(k) Number": "K173263",
    "Predicate Device Reference 510(k) Number(s)": [
        "K160901"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "POC",
        "OOI",
        "PMY"
    ],
    "Summary Letter Date": "October 10, 2017",
    "Summary Letter Received Date": "October 12, 2017",
    "Submission Date": "January 04, 2018",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial susceptibility test powder"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "blaKPC",
        "blaNDM",
        "blaVIM",
        "blaOXA-48",
        "blaIMP"
    ],
    "Specimen Type(s)": [
        "Rectal swab",
        "Perirectal swab",
        "Pure colonies from bacterial isolates"
    ],
    "Specimen Container(s)": [
        "Blood agar plate",
        "MacConkey agar plate",
        "Cepheid Specimen Collection Device"
    ],
    "Instrument(s)/Platform(s)": [
        "GeneXpert Instrument System",
        "GeneXpert Dx",
        "GeneXpert Infinity-48",
        "GeneXpert Infinity-48s",
        "GeneXpert Infinity-80"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Automated nucleic acid amplification",
        "Multiplex PCR"
    ],
    "Methodologies": [
        "Qualitative nucleic acid amplification",
        "Real-time PCR",
        "Multiplex PCR"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for Cepheid Xpert Carba-R Assay, a qualitative automated PCR test for detection of carbapenemase resistance genes (blaKPC, blaNDM, blaVIM, blaOXA-48, blaIMP) from rectal/perirectal swabs and pure colonies, performed on the GeneXpert system.",
    "Indications for Use Summary": "Qualitative in vitro diagnostic to detect and differentiate blaKPC, blaNDM, blaVIM, blaOXA-48, and blaIMP gene sequences associated with carbapenem-non-susceptibility in Gram-negative bacteria from rectal or perirectal swabs and pure culture isolates; aids infection control but not for guiding treatment.",
    "fda_folder": "Microbiology"
}